Last updated on March 2017

"A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine"

---

Brief description of study

"A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine"

Detailed Study Description

A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous administration of TEV-48125 in adult patients with chronic migraine or episodic migraine